The future of antimicrobials

Our business :
The post antibiotics era

Biofilm Pharma was founded in 2017 as a part of the Biofilm Technologies Group.

Biofilm Pharma benefits from the experience, technological leadership and patents of the Biofilm Technologies Group in its efforts of discovering and designing the future of antimicrobial drugs.

At Biofilm Pharma,
we have one goal :
re-inventing antimicrobials to transform the way to cure infections

Thierry BERNARDI, CEO of Biofilm Pharma

Next generation antimicrobials
must be antibiofilms

Severe and chronic infections are now known to be caused by bacterial biofilms, a bacterial behavior which promotes adhesion to a surface and improve antimicrobial resistance.

When it comes to cure biofilm infections existing antibiotics therapies are ineffectives.

At Biofilm Pharma, we have an innovative approach, based on products which prevent bacterial adhesion (antibiofilm) without killing the bacterias (non antibiotic) and thus preserving the positive microbiote.

Cutting-edge technology
for first-in-class drugs

Biofilm Pharma uses its proprietary High Troughput Screening robotic plateform in an unprecedented screening campaign of antimicrobial molecules with an anti-biofilm added value.

Our screening is unique thanks to the use of a patented technology of the Biofilm Technologies Group : the Biofilm Ring Test®. This technology is the only one to focus on bacterial adhesion, in a reliable and standardized way.

We are the only ones to have access to this information : that’s the Biofilm Pharma advantage !!!

Products Pipelines

BFP001 : Antibiofilm non antibiotic. Indications : Local, Diabetic Foot Ulcer, Joint & Bone Infections

BFP002 : Antibiofilm non antibiotic. Indications : Cystic Fibrosis

BFP101 : Antibiofilm antibiotic. Indications : Local, Diabetic Foot Ulcer, Joint & Bone Infections

BFP102 : Antibiofilm antibiotic. Indications : Cystic Fibrosis

Become a part
of the revolution

Biofilm Pharma has already financed its first project of antimicrobial treatements.

We are still searching for new investments and partnerships to devellop our panel of drug candidates targeting chronic infections.

Seize the opportunity
to access a unexplored pharmaceutical market and being a pioneer in the new world of antimicrobials.

Our goal
Our values
Our philosophy

A video introduction to the Biofilm Pharma projects.

Short presentation
of the company

Download